News | March 14, 2024
Zydus launches generic version of Olaparib ‘IBYRA’ in India
The drug will target specific genetic mutations prevalent in certain types of cancers
The drug will target specific genetic mutations prevalent in certain types of cancers
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
Profit after tax (before exceptional items) up 23% to Rs 215 crores
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
Subscribe To Our Newsletter & Stay Updated
